102671-59-0

Basic information

• Product Name: (6-methoxy-pyridin-3-yl)-carbamic acid phenyl ester
• Synonyms: (6-methoxy-pyridin-3-yl)-carbamic acid phenyl ester
• CAS NO: 102671-59-0
• Molecular Weight: 244.25
• Mol File: 102671-59-0.mol
• Article Data: 9

Chemical Properties

• CAS DataBase Reference: (6-methoxy-pyridin-3-yl)-carbamic acid phenyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (6-methoxy-pyridin-3-yl)-carbamic acid phenyl ester(102671-59-0)
• EPA Substance Registry System: (6-methoxy-pyridin-3-yl)-carbamic acid phenyl ester(102671-59-0)

Safety Data

• Hazardous Substances Data: 102671-59-0(Hazardous Substances Data)

Upstream product

• 6628-77-9 6-methoxy-pyridin-3-ylamine 
• 1885-14-9 phenyl chloroformate 
• 108-95-2 phenol 

Downstream Products

• 1191286-43-7 (4E)-N-(6-methoxypyridin-3-yl)-3-methyl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide 
• 1020315-49-4 N-(6-methoxypyridin-3-yl)-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide 

Relevant articles and documents

Unprecedented "in water" imidazole carbonylation: Paradigm shift for preparation of urea and carbamate

The first "In Water" imidazolecarbonylation of amine is described. A one pot reaction of carbonylimidazolide in water with a nucleophile provides an efficient and general method for the preparation of urea, carbamates and thiocarbamates. Use of an anhydrous solvent and an inert atmosphere could be avoided. Product precipitate out from the reaction mixture and can be obtained in high purity by filtration, resulting in a simple and scalable method.

4- [3- (ARYLOXY) BENZYLIDENE] -3-METHYL PIPERIDINE ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS

The present invention relates to compounds of Formula (I), wherein Ar is optionally substituted phenyl or heteroaryl and X, Y and Z are independently N or CH; or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity.

BIARYL ETHER UREA COMPOUNDS

The present invention relates to compounds of Formula (I) or a pharmaceutically acceptable salt thereof; processes for the preparation of the compounds; intermediates used in the preparation of the compounds; compositions containing the compounds; and uses of the compounds in treating diseases or conditions associated with fatty acid amide hydrolase (FAAH) activity